Emerson c. Perin,
Leslie W. Miller,
Doris A. Taylor,
Doris Taylor,
James T. Willerson
e.a.
Elsevier Science
e druk, 2015
9780128018880
Stem Cell and Gene Therapy for Cardiovascular Disease
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
2015
ISBN13: 9780128018880
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Stem Cell and Gene Therapy for Cardiovascular Disease is a state-of-the-art reference that combines, in one place, the breadth and depth of information available on the topic.
As stem cell and gene therapies are the most cutting-edge therapies currently available for patients with heart failure, each section of the book provides information on medical trials from contributors and specialists from around the world, including not only what has been completed, but also what is planned for future research and trials.
Cardiology researchers, basic science clinicians, fellows, residents, students, and industry professionals will find this book an invaluable resource for further study on the topic.
Specificaties
Inhoudsopgave
1. Introduction and Overview of Stem Cells<br>2. Mechanistic Insights from Pathologic Perspective<br>3. Large Animal Models to Study Stem Cell Therapy<br>4. Evolution of understanding of the mechanisms of repair<br>5. Impact of Age on Stem Cell Function<br>6. Bone Marrow Mononuclear Cells<br>7. Chronic Limb Ischemia<br>8. Chronic/Refractory Angina<br>9. Acute Myocardial Infarction<br>A. European Experience<br>B. US Experience<br>10. Chronic Ischemic Heart Failure<br>11. Adipose Tissue<br>12. Overview of MSCs <br>13. Allogeneic vs Autologous Source: Comparative Effects<br>14. Use of MSCs for AMI<br>15. Combined Cell Strategies<br>16. Heart Failure<br>17. C-Kit+ cells<br>18. Cardiospheres<br>19. Umbilical Cord, Placenta, Endometrium<br>20. Genetic Engineering of Fibroblasts to Cardiomyocytes<br>21. Transformation to inducible Pleuripotent Stem Cells<br>22. Transformation to MAPC's<br>23. Transcoronary and Endocardial<br>24. Retrograde and Epicardial<br>25. Epicardial Patch<br>26. Matrix Scaffolds<br>27. Matrix plus cells <br>28. Biomaterial: Alginate<br>29. Organogenesis<br>30. Pre-clinical Identification of target genes<br>31. SERCA-2a gene for recovery of inotropic function<br>32. SDF-1 Gene for Heart Failure Non-Inotropic Mechanisms<br>33. Gene Therapy for Angiogenesis: Chronic Limb Ischemia <br>34. Stem Cells Target Gene Transfected Stem Cells<br>35. CCTRN: Past, Present, and Vision for the Future<br>36. Signature of Responders-lessons from Bio-Repository<br>37. Adjunctive therapy with LVADs for Recovery<br>38. Trials in Non-Ischemic Heart Failure<br>39. Enhancing Stem Cell Homing for Tissue Repair<br>40. Stroke: Pre-Clinical and Clinical Trial Data